Clinical Trial

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants

Name: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants — clinical trial record (NCT07422207)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-07

Trial Details

NCT Number	NCT07422207
Lead Sponsor	Meiji Pharma USA Inc.
Conditions	Healthy Volunteers
Enrollment	104 participants
Start Date	2026-03-23
Primary Completion	2027-07 (estimated)
Study Completion	2027-07 (estimated)
Updated on ClinicalTrials.gov	2026-04-06